The idea of repairing damaged heart tissue with donated cells is an old one, but finding cells that can do the job has been frustrating. The solution may come from a select group of bone marrow cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Orlic, D. et al. Nature 410, 701–705 (2001).
Reinlib, L. & Field, F. Circulation 101,E182–E187 (2000).
Kessler, P. D. & Byrne, B. J. Annu. Rev. Physiol. 61, 219–242 (1999).
Tomita, S. et al. Circulation 100(Suppl. II), 247–256 (1999).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sussman, M. Hearts and bones. Nature 410, 640–641 (2001). https://doi.org/10.1038/35070687
Issue Date:
DOI: https://doi.org/10.1038/35070687
This article is cited by
-
On the Road to Regeneration: “Tools” and “Routes” Towards Efficient Cardiac Cell Therapy for Ischemic Cardiomyopathy
Current Cardiology Reports (2019)
-
Mesenchymal stem cells are superior to angiogenic growth factor genes for improving myocardial performance in the mouse model of acute myocardial infarction
Journal of Biomedical Science (2006)
-
Induced differentiation of human cord blood mesenchymal stem/progenitor cells into cardiomyocyte-like cellsin vitro
Current Medical Science (2003)
-
Can they rebuild us?
Nature (2001)
